Vnebol'nichnaya pnevmoniya: diagnostika i antibakterial'naya terapiya
- Authors: Dvoretskiy L.I1
-
Affiliations:
- ММА им. И.М.Сеченова
- Issue: Vol 8, No 3 (2006)
- Pages: 25-30
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/92080
- ID: 92080
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##References
- Чучалин А.Г. В кн. Пневмонии. Ред. А.Г.Чучалин. А.И.Синопальников, Н.Е.Черняховская. М.: Экономика и информатика. 2002.
- Fine M.J, Auble T.E, Yealy D.M et al. A prediction rule to identify low - risk patients with community acquired - pneumonia. New Engl J Med 1997; 336: 243–50.
- Meehan T.P, Fine M.J, Krumholz H.M et al. Quality of care process and outcomes in elderly patients with pneumonia JAMA 1997; 278: 2080.
- Houck P.M, Mac Lehose R.F, Niederman M.S et al. Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 Western States: 1993, 1995, and 1997. Chest 2001; 119: 1420–6.
- Fine M.N, Smith M.F, Carson C.A et al. Prognosis and outcomes of patients with community - acquired pntumonia. JAMA 1996; 275: 134–42.
- Mandell L.A, Marrie T.J, Grossman R.E et al. Canadian guidlines for the initial management of community - acquired pneumonia. Clin Infect Dis 2000; 31: 383–421.
- Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community - acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005; 165 (17): 1992–2000.
- Mills G.D, Oehley M.R, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non - severe community acquired pneumonia: meta - analysis. BMJ 2005; 330 (7489): 456.
- Яковлев С.В. Спирамицин. Монография. Москва: Rhone-Poulenc Rorer. 1997–72.
Supplementary files
